We are live on ! Find out more
IRMD icon

iRadimed

168 hedge funds and large institutions have $365M invested in iRadimed in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 51 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 51

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1% more funds holding

Funds holding: 167168 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.29% less ownership

Funds ownership: 55.01%54.73% (-0.29%)

5% less capital invested

Capital invested by funds: $383M → $365M (-$18.1M)

97% less call options, than puts

Call options by funds: $5K | Put options by funds: $167K

Holders
168
Holders Change
+1
Holders Change %
+0.6%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
70
Reduced
51
Closed
17
Calls
$5K
Puts
$167K
Net Calls
-$162K
Net Calls Change
+$30K

IRMD Hedge Fund Activity: Q1 2025 in Review

168 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2025, worth a combined $365M — down 4.7% from $383M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IRMD positions and 17 closed out — a net gain of 1 holder — while 70 added to existing stakes and 51 trimmed.

The largest buyer was Roubaix Capital, opening a new position worth an estimated $2.7M. The largest seller was Ranger Investment Management, cutting an estimated $2.51M.

  • 168 institutional investors held iRadimed (IRMD) as of Q1 2025, up from 167 in Q4 2024.
  • Funds reported $365M of iRadimed stock for Q1 2025, down 4.7% quarter-over-quarter.
  • 18 funds opened new iRadimed positions in Q1 2025 and 17 closed out, a net change of +1 holder.
  • The largest iRadimed buyer in Q1 2025 was Roubaix Capital, an estimated $2.7M added.
  • The largest iRadimed seller in Q1 2025 was Ranger Investment Management, an estimated $2.51M sold.

Based on aggregated 13F filings for Q1 2025.